CareDx, Inc. - stock earnings
CDNA Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 2, 2024 AfterMarket | - / -0.1958000000 | - | - / 64.8 million | - |
CDNA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -118.1 million USD | 65.6 million USD |
| 2023Q3 | -23.5 million USD | 67.2 million USD |
| 2023Q2 | -25.0 million USD | 70.3 million USD |
| 2023Q1 | -23.7 million USD | 77.3 million USD |
| 2022Q4 | -18.3 million USD | 82.4 million USD |
| 2022Q3 | -16.9 million USD | 79.4 million USD |
| 2022Q2 | -21.7 million USD | 80.6 million USD |
| 2022Q1 | -19.6 million USD | 79.4 million USD |
| 2021Q4 | -16.2 million USD | 79.2 million USD |
| 2021Q3 | -11.9 million USD | 75.6 million USD |
| 2021Q2 | -1.9 million USD | 74.2 million USD |
| 2021Q1 | -687000 USD | 67.4 million USD |
| 2020Q4 | -3.5 million USD | 58.6 million USD |
| 2020Q3 | -2.8 million USD | 53.4 million USD |
| 2020Q2 | -6.6 million USD | 41.8 million USD |
| 2020Q1 | -5.8 million USD | 38.4 million USD |
| 2019Q4 | -4.8 million USD | 35.8 million USD |
| 2019Q3 | -1.8 million USD | 33.8 million USD |
| 2019Q2 | -7.8 million USD | 31.5 million USD |
| 2019Q1 | -7.5 million USD | 26.0 million USD |
| 2018Q4 | -3.8 million USD | 23.5 million USD |
| 2018Q3 | -20.0 million USD | 21.2 million USD |
| 2018Q2 | -14.1 million USD | 17.8 million USD |
| 2018Q1 | -9.0 million USD | 14.1 million USD |
| 2017Q4 | -31.7 million USD | 12.5 million USD |
| 2017Q3 | -14.3 million USD | 12.2 million USD |
| 2017Q2 | -4.0 million USD | 12.0 million USD |
| 2017Q1 | -15.5 million USD | 10.9 million USD |
| 2016Q4 | -15.5 million USD | 10.9 million USD |
| 2016Q3 | -3.8 million USD | 12.5 million USD |
| 2016Q2 | -10.3 million USD | 10.7 million USD |
| 2016Q1 | -9.8 million USD | 6.6 million USD |
| 2015Q4 | -4.8 million USD | 6.6 million USD |
| 2015Q3 | -3.5 million USD | 7.2 million USD |
| 2015Q2 | -3.2 million USD | 7.1 million USD |
| 2015Q1 | -2.3 million USD | 7.2 million USD |
| 2014Q4 | -5000 USD | 8.0 million USD |
| 2014Q3 | 1.2 million USD | 6.7 million USD |
| 2014Q2 | 877000 USD | 6.8 million USD |
| 2014Q1 | -1.3 million USD | 5.9 million USD |
| 2013Q4 | -562000 USD | 5.9 million USD |
| 2013Q3 | -830000 USD | 5.8 million USD |
| 2013Q2 | -802000 USD | 5.5 million USD |
| 2013Q1 | -1.3 million USD | 5.0 million USD |
| 2012Q4 | ? USD | 20.5 million USD |
| 2006Q4 | ? USD | 2.9 million USD |
| 2005Q4 | ? USD | 327000 USD |
CDNA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -190.3 million USD | 280.3 million USD |
| 2022 | -76.6 million USD | 321.8 million USD |
| 2021 | -30.7 million USD | 296.4 million USD |
| 2020 | -18.7 million USD | 192.2 million USD |
| 2019 | -22.0 million USD | 127.1 million USD |
| 2018 | -46.8 million USD | 76.6 million USD |
| 2017 | -55.5 million USD | 48.3 million USD |
| 2016 | -39.5 million USD | 40.6 million USD |
| 2015 | -13.7 million USD | 28.1 million USD |
| 2014 | 781000 USD | 27.3 million USD |
| 2013 | -3.5 million USD | 22.1 million USD |
| 2012 | -5.1 million USD | 20.5 million USD |
CDNA
Price: $9.72
52 week price:
Earnings Per Share: -3.54 USD
P/E Ratio: -5.07
Exchange: NGM
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 944000
Ebitda: -11.9 millionMarket Capitalization: 519.9 million